AdvaMeDx Strengthensits Management Team AdvaMeDx has added a veteran policy analyst to its ranks.

AdvaMeDx Strengthensits Management Team

AdvaMeDx has added a veteran policy analyst to its ranks.

Tharini Sathiamoorthy is the group’s new associate vice president, according to a news release from the organization. Sathiamoorthy brings a decade of experience in public and government affairs and health policy analysis to the position, having served most recently as senior associate in the health policy practice at global public affairs firm APCO Worldwide Inc. During her tenure at APCO, Sathiamoorthy performed federal policy outreach and analysis work and crafted stakeholder and ally development programs for various clients, including medical device and diagnostics manufacturers.

Before she joined APCO, Sathiamoorthy managed Medicare and Medicaid projects for two healthcare advisory firms—The Lewin Group, a 15-year-old company based in Falls Church, Va., and The Marwood Group, headquartered in New York, N.Y. Earlier in her career, Sathiamoorthy coordinated government affairs and health policy activities for the American College of Physicians, a Philadelphia, Pa.-based national group of internists whose 130,000 members include internal medicine subspecialists, internists, medical students, residents and fellows. She also was a legislative analystfor Dean Blakey & Moskowitz, a management consulting services firm based inWashington, D.C.

“Tharini’s extensive expertise working with federal policy makers, providing health policy analysis and developing strategic alliances will be instrumental in advancing the advocacy efforts important to AdvaMeDx,” Andrew Fish, AdvaMeDx executive director, said in a prepared statement. “Tharini will be a valuable asset in our mission to provide timely patient access to safe and effective diagnostic tests by establishing risk-based regulation and modernizing the antiquated Medicarepayment system.”

AdvaMeDx is a division of the Advanced Medical Technology Association (AdvaMed) that focuses solely on in-vitro diagnostic technologies. While the group draws its support from AdvaMed’s vast resources, it maintains its own strategic policy and advocacy priorities, including: developing industry standards and statistics; advocating for domestic and international payment and regulatory policies for the diagnostics sector; and facilitating the adoption of diagnostic devices.